Best Practices, LLC Home
View Cart Search the Site Contact Best Practices, LLC Press Room of Best Practices, LLC
ABOUT US RESEARCH & CONSULTING BENCHMARKING REPORTS BEST PRACTICE DATABASE RESEARCH & ADVISORY SERVICES BEST PRACTICES EXCELLENCE SERVICES
Sales and Marketing > New Product Development and Launch

New Product Development and Launch Research

Clinical Trial Excellence Library Service 
Excellent clinical trials can significantly reduce costs by preventing delayed product launch due to trial length... (ID OPS-85)
Companies Profiled: 3M Pharmaceuticals, Sanofi-aventis, AAI Corporation, AAI Development, more ...
Price: $23100.00   Free Excerpt Available


R&D Quality Assurance Excellence Library 
A must-have for all pharmaceutical, biotech and medical device manufacturing executives, this Best Practices' R&D Quality Assurance bundle tells you everything you need to know about quality... (ID OPS-95)
Companies Profiled: aaiPharma, Sanofi-aventis, Abbott, Abbott Laboratories, more ...
Price: $21100.00   Free Excerpt Available


Market Research Excellence: Research and the Unfair Competitive Advantage 
Best Practices’ Market Research series highlights best practices in market research... (ID SMS-169)
Companies Profiled: 3M Pharmaceuticals, Sanofi-aventis, aaiPharma, Abbott Laboratories, more ...
Price: $20735.00   Free Excerpt Available


Pharma Thought Leadership: Be a Thought Leader, Manage Influential Organizations, Launch a Winner 
Best Practices’ Pharma Thought Leadership series examines thought leadership in the context of patient advocacy while creating effective relationships and global product launches... (ID SMS-156)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, AstraZeneca, Bristol-Myers Squibb, more ...
Price: $18400.00


Pharmaceutical New Product Planning: Structure and Activities to Drive Growth and Profitability 
Pharmaceutical and biotech companies are increasingly under pressure to deliver effective new products in shorter time frames while minimizing development costs... (ID PSM-229)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, Actelion, Alcon, more ...
Price: $9000.00   Free Excerpt Available


Success Factors and Failure Points in Oncology Product Launches 
The biopharmaceutical sector has seen dozens of new product launches in the last few years, including some notable new drugs targeting the oncology therapeutic area... (ID PSM-267)
Companies Profiled: GlaxoSmithKline , Bristol-Myers Squibb, Roche, Lilly, more ...
Price: $8500.00   Free Excerpt Available


Success Factors and Failure Points in Metabolic Product Launches 
The biopharmaceutical sector has seen dozens of new product launches in the last few years, including some notable new drugs targeting the metabolic therapeutic area... (ID PSM-266)
Companies Profiled: GlaxoSmithKline , Bristol-Myers Squibb, Roche, Lilly, more ...
Price: $8500.00   Free Excerpt Available


Success Factors and Failure Points in Cardiovascular Product Launches 
The biopharmaceutical sector has seen dozens of new product launches in the last few years, including some notable new drugs targeting the cardiovascular therapeutic area... (ID PSM-264)
Companies Profiled: GlaxoSmithKline , Bristol-Myers Squibb, Roche, Lilly, more ...
Price: $8500.00   Free Excerpt Available


Success Factors and Failure Points in Biopharmaceutical Product Launches: An Updated Road Map for Strong Market Entry 
The last several years have been marked by dozens of pharmaceutical product launches; some products took off at launch while many others fell flat... (ID PSM-261)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $8500.00   Free Excerpt Available


New Product Launch Spend: What It Takes To Win In The U.S. Market 
In today’s pharmaceutical industry–where the recent product launch landscape is marked by as many failures as successes—it is critical for launch teams to understand the right level of resources required to give each new product its best chance for gaining a market foothold... (ID PSM-262)
Companies Profiled: Abbott, ProStrakan, Sanofi-aventis, Regeneron, more ...
Price: $8000.00   Free Excerpt Available


Educating KOLs, Physicians, Patients and Payers to Support Successful Product Launches 
The bio-pharmaceutical marketplace continues to evolve as new medicines and technologies create valuable market opportunities... (ID PSM-248)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...
Price: $8000.00   Free Excerpt Available


Educating the Marketplace to Support Successful Diabetes Product Launches 
The bio-pharmaceutical marketplace – including the diabetes therapeutic area – continues to evolve as new medicines and technologies create valuable market opportunities... (ID PSM-246)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...
Price: $8000.00   Free Excerpt Available


Shaping the Marketplace to Support Successful Oncology Product Launches: Tactics for Educating KOLs, Physicians, Patients and Payers 
The bio-pharmaceutical marketplace – and the oncology therapeutic area in particular – continues to evolve as new medicines and technologies create valuable market opportunities... (ID PSM-243)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...
Price: $8000.00   Free Excerpt Available


Launching Pharmaceutical Megabrands: Best Practices in Marketing Blockbusters 
The findings in this Best Practices Benchmarking® Report will enable pharmaceutical executives to understand the winning strategies, practices, team structures and investment patterns that distinguish successful new product development and marketing planning... (ID SM-124)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, Bristol-Myers Squibb, Amgen, more ...
Price: $7962.00   Free Excerpt Available


Pharmaceutical New Product Commercialization: Preparing for Market Success 
Long and costly product development cycles make it essential for pharmaceutical companies to maximize limited staff and resources to the development of compounds with the greatest potential market value... (ID SM-176)
Companies Profiled: Abbott, Allergan, Alexion Pharmaceuticals, Altus Biologics, more ...
Price: $7795.00   Free Excerpt Available


Best Practices in Working with Patient Advocacy Groups: Building Effective Relationships 
Patient and professional advocacy groups play a crucial role in educating the marketplace on new medicines and treatments... (ID SM-185)
Companies Profiled: Abaxis, Abbott Laboratories, Allos Therapeutics, Amgen, more ...
Price: $7500.00   Free Excerpt Available


Best Practices for Internal Communications Regarding Brands & Disease State 
When a promising new pharmaceutical product fails to meet expectations, poor brand communications may be a contributing cause... (ID POP-229)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, Actelion, Boehringer Ingelheim, more ...
Price: $7400.00   Free Excerpt Available


Raising Disease State Awareness: Best Practices in Internal Brand Messaging for New Products 
Educating the marketplace about disease state is crucial to the success of a new pharmaceutical product— especially if the product treats a medical condition that is previously unknown, socially sensitive or stigmatized or if the product is first in its class... (ID OP-106)
Companies Profiled: Abbott, Novartis, Actelion, Novo Nordisk, more ...
Price: $7200.00   Free Excerpt Available


Driving Growth Through Planning, Structure and Activities: Best Practices in Pharmaceutical New Product Planning 
New products are the lifeblood of any biopharma company and organizations are increasingly under pressure to deliver effective products in shorter time frames... (ID SM-182)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, Actelion, Alcon, more ...
Price: $7000.00   Free Excerpt Available


Best Practices in Global Pharmaceutical Launches 
Discover how the world's leading pharmaceutical companies develop global launch strategies, manage launch teams, cultivate thought leader support, integrate marketing activities, and conduct a host of other critical launch activities... (ID SM-120)
Companies Profiled: Merck, Sanofi-aventis, Eli Lilly, Wyeth, more ...
Price: $7000.00   Free Excerpt Available


Educating the Market to Support Successful Product Launches in Oncology 
Click Download link on right for complimentary excerpt Aggressive market pressures challenge companies to rapidly deliver new products in the market and at the same time ensure markets are well informed about in-line product launches... (ID SM-190)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...
Price: $6800.00   Free Excerpt Available


 


All contents copyright 1998-2012 Best Practices, LLC (919) 403-0251
Site Map | Read our Privacy Policy and Copyright Information